These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 35478141)

  • 1. Establishment of Patient-derived Orthotopic Xenografts (PDX) as Models for Pancreatic Ductal Adenocarcinoma.
    Magouliotis DE; Lafazanis K; Koutsougianni F; Sakellaridis N; Ioannou M; Zacharoulis D; Dimas K
    In Vivo; 2022; 36(3):1114-1119. PubMed ID: 35478141
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oncological and genetic factors impacting PDX model construction with NSG mice in pancreatic cancer.
    Guo S; Gao S; Liu R; Shen J; Shi X; Bai S; Wang H; Zheng K; Shao Z; Liang C; Peng S; Jin G
    FASEB J; 2019 Jan; 33(1):873-884. PubMed ID: 30091943
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Optimal Organ for Patient-derived Xenograft Model in Pancreatic Cancer and Microenvironment that Contributes to Success.
    Eguchi S; Kimura K; Kageyama K; Tani N; Tanaka R; Nishio K; Shinkawa H; Ohira GO; Amano R; Tanaka S; Yamamoto A; Takemura S; Yashiro M; Kubo S
    Anticancer Res; 2022 May; 42(5):2395-2404. PubMed ID: 35489770
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Surgical and Oncological Factors Affecting the Successful Engraftment of Patient-derived Xenografts in Pancreatic Ductal Adenocarcinoma.
    Jun E; Jung J; Jeong SY; Choi EK; Kim MB; Lee JS; Hong SM; Seol HS; Hwang C; Hoffman RM; Shim IK; Chang S; Kim SC
    Anticancer Res; 2016 Feb; 36(2):517-21. PubMed ID: 26851005
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A fast, simple, and cost-effective method of expanding patient-derived xenograft mouse models of pancreatic ductal adenocarcinoma.
    Liu Z; Ahn MH; Kurokawa T; Ly A; Zhang G; Wang F; Yamada T; Sadagopan A; Cheng J; Ferrone CR; Liss AS; Honselmann KC; Wojtkiewicz GR; Ferrone S; Wang X
    J Transl Med; 2020 Jun; 18(1):255. PubMed ID: 32580742
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Establishment of a Liver Transplant Patient-derived Tumor Xenograft (PDX) Model Using Cryopreserved Pancreatic Ductal Adenocarcinoma.
    Tanaka R; Kageyama K; Kimura K; Eguchi S; Tauchi J; Shinkawa H; Ohira GO; Yamazoe S; Yamamoto A; Tanaka S; Amano R; Tanaka H; Yashiro M; Kubo S; Ohira M
    Anticancer Res; 2020 May; 40(5):2637-2644. PubMed ID: 32366408
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ex Vivo Testing of Patient-Derived Xenografts Mirrors the Clinical Outcome of Patients with Pancreatic Ductal Adenocarcinoma.
    Roife D; Dai B; Kang Y; Perez MVR; Pratt M; Li X; Fleming JB
    Clin Cancer Res; 2016 Dec; 22(24):6021-6030. PubMed ID: 27259561
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aspartate β-hydroxylase promotes pancreatic ductal adenocarcinoma metastasis through activation of SRC signaling pathway.
    Ogawa K; Lin Q; Li L; Bai X; Chen X; Chen H; Kong R; Wang Y; Zhu H; He F; Xu Q; Liu L; Li M; Zhang S; Nagaoka K; Carlson R; Safran H; Charpentier K; Sun B; Wands J; Dong X
    J Hematol Oncol; 2019 Dec; 12(1):144. PubMed ID: 31888763
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumor engraftment in patient-derived xenografts of pancreatic ductal adenocarcinoma is associated with adverse clinicopathological features and poor survival.
    Pergolini I; Morales-Oyarvide V; Mino-Kenudson M; Honselmann KC; Rosenbaum MW; Nahar S; Kem M; Ferrone CR; Lillemoe KD; Bardeesy N; Ryan DP; Thayer SP; Warshaw AL; Fernández-Del Castillo C; Liss AS
    PLoS One; 2017; 12(8):e0182855. PubMed ID: 28854237
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel patient-derived orthotopic xenograft model of esophageal adenocarcinoma provides a platform for translational discoveries.
    Veeranki OL; Tong Z; Mejia A; Verma A; Katkhuda R; Bassett R; Kim TB; Wang J; Lang W; Mino B; Solis L; Kingsley C; Norton W; Tailor R; Wu JY; Krishnan S; Lin SH; Blum M; Hofstetter W; Ajani J; Kopetz S; Maru D
    Dis Model Mech; 2019 Dec; 12(12):. PubMed ID: 31732509
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Patient-derived xenograft models for pancreatic adenocarcinoma demonstrate retention of tumor morphology through incorporation of murine stromal elements.
    Delitto D; Pham K; Vlada AC; Sarosi GA; Thomas RM; Behrns KE; Liu C; Hughes SJ; Wallet SM; Trevino JG
    Am J Pathol; 2015 May; 185(5):1297-303. PubMed ID: 25770474
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A gene expression signature of epithelial tubulogenesis and a role for ASPM in pancreatic tumor progression.
    Wang WY; Hsu CC; Wang TY; Li CR; Hou YC; Chu JM; Lee CT; Liu MS; Su JJ; Jian KY; Huang SS; Jiang SS; Shan YS; Lin PW; Shen YY; Lee MT; Chan TS; Chang CC; Chen CH; Chang IS; Lee YL; Chen LT; Tsai KK
    Gastroenterology; 2013 Nov; 145(5):1110-20. PubMed ID: 23896173
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Patient-derived xenografts of gastrointestinal cancers are susceptible to rapid and delayed B-lymphoproliferation.
    Dieter SM; Giessler KM; Kriegsmann M; Dubash TD; Möhrmann L; Schulz ER; Siegl C; Weber S; Strakerjahn H; Oberlack A; Heger U; Gao J; Hartinger EM; Oppel F; Hoffmann CM; Ha N; Brors B; Lasitschka F; Ulrich A; Strobel O; Schmidt M; von Kalle C; Schneider M; Weichert W; Ehrenberg KR; Glimm H; Ball CR
    Int J Cancer; 2017 Mar; 140(6):1356-1363. PubMed ID: 27935045
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intestinal microbiota enhances pancreatic carcinogenesis in preclinical models.
    Thomas RM; Gharaibeh RZ; Gauthier J; Beveridge M; Pope JL; Guijarro MV; Yu Q; He Z; Ohland C; Newsome R; Trevino J; Hughes SJ; Reinhard M; Winglee K; Fodor AA; Zajac-Kaye M; Jobin C
    Carcinogenesis; 2018 Jul; 39(8):1068-1078. PubMed ID: 29846515
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thrombin Signaling Promotes Pancreatic Adenocarcinoma through PAR-1-Dependent Immune Evasion.
    Yang Y; Stang A; Schweickert PG; Lanman NA; Paul EN; Monia BP; Revenko AS; Palumbo JS; Mullins ES; Elzey BD; Janssen EM; Konieczny SF; Flick MJ
    Cancer Res; 2019 Jul; 79(13):3417-3430. PubMed ID: 31048498
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumor characteristics associated with engraftment of patient-derived non-small cell lung cancer xenografts in immunocompromised mice.
    Chen Y; Zhang R; Wang L; Correa AM; Pataer A; Xu Y; Zhang X; Ren C; Wu S; Meng QH; Fujimoto J; Jensen VB; Antonoff MB; Hofstetter WL; Mehran RJ; Pisimisis G; Rice DC; Sepesi B; Vaporciyan AA; Walsh GL; Swisher SG; Roth JA; Heymach JV; Fang B
    Cancer; 2019 Nov; 125(21):3738-3748. PubMed ID: 31287557
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Patient-Derived Xenografts Can Be Reliably Generated from Patient Clinical Biopsy Specimens.
    Hernandez MC; Bergquist JR; Leiting JL; Ivanics T; Yang L; Smoot RL; Nagorney DM; Truty MJ
    J Gastrointest Surg; 2019 Apr; 23(4):818-824. PubMed ID: 30756315
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Orthotopic Patient-Derived Pancreatic Cancer Xenografts Engraft Into the Pancreatic Parenchyma, Metastasize, and Induce Muscle Wasting to Recapitulate the Human Disease.
    Go KL; Delitto D; Judge SM; Gerber MH; George TJ; Behrns KE; Hughes SJ; Judge AR; Trevino JG
    Pancreas; 2017 Jul; 46(6):813-819. PubMed ID: 28609371
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A rat-based preclinical platform facilitating transcatheter hepatic arterial infusion in immunodeficient rats with liver xenografts of patient-derived pancreatic ductal adenocarcinoma.
    Ozaki M; Kageyama K; Kimura K; Eguchi S; Yamamoto A; Tanaka R; Nota T; Yonezawa H; Nishiofuku H; Sakai Y; Tani N; Jogo A; Terai M; Sato T; Ishizawa T; Miki Y
    Sci Rep; 2024 May; 14(1):10529. PubMed ID: 38719893
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Humanized Patient-Derived Xenograft Model for Pancreatic Cancer.
    Lundy J
    Methods Mol Biol; 2024; 2806():91-100. PubMed ID: 38676798
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.